Drug-resistant bacterial infections reported in 20 states, worldwide
ARLINGTON, Va. Drug-resistant bacterial infections recently have been reported in more than 20 states across the United States, and now are responsible for an outbreak in Tel Aviv, Israel, according to a report in USA Today on Thursday, citing information from the Society for Healthcare Epidemiology of America.
The bacterial infections prove fatal in as many as 60% of all cases.
The outbreak in Tel Aviv has been traced to northern New Jersey, Neil Fishman, director of SHEA, told the national daily. The bacteria in question are equipped with a gene that enables them to produce an enzyme that disables antibiotics. The enzyme is called Klebsiella pneumoniae carbapenamase, or KPC. It disables carbapenem antibiotics, or last-ditch treatments for infections that don’t respond to other drugs.
The infections are taking place primarily in hospital settings and have not yet spread to the general community.
The problem may be of greater concern than methicillin-resistant Staphylococcus aureus, or MRSA, given the number of alternative treatments that are available. The only drug that appears to make any headway against carbapenem-resistant germs is polymyxin, a medicine that has fallen out of favor with doctors given the toxicity to the kidneys, Fishman said.
Abbott expands Ensure shakes line
ABBOTT PARK, Ill. Abbott on Thursday introduced two new nutrition shakes — Ensure Muscle Health and Ensure Clinical Strength — both formulated to help rebuild muscle mass naturally lost with age.
Ensure Muscle Health shakes contain Abbott’s proprietary ingredient, Revigor, a source of HMB (beta-hydroxy-beta-methylbutyrate, an amino-acid metabolite), and 13 g of protein.
“Abbott scientists have been studying muscle loss for more than a decade,” stated Rob Miller, divisional VP global research and development and scientific affairs. “We’ve taken our expertise with HMB, the ingredient that has been clinically shown to support muscle mass and functionality in healthy, exercising adults, and have added it to one of our therapeutic nutrition products for people over 40 who are naturally losing muscle with age.”
Ensure Clinical Strength shakes offer focused clinical nutrition, coupling the benefits of Revigor and protein with Immune Balance, a unique blend of prebiotic fiber to support digestive tract health and antioxidants to support the immune system.
Clinical research has shown that beginning around 40 years of age, people can start to lose 8% of muscle mass per decade, which can lead to loss of strength and mobility. Weakness, fatigue, low energy and weight loss are signals of muscle loss.
In addition to two new innovative nutrition shakes, Abbott recently relaunched its product line and introduced a new, streamlined look for the Ensure brand. With an updated logo and packaging, it is easier for consumers to find the Ensure shake to fit their nutritional needs, whether it’s Ensure Muscle Health, Ensure Clinical Strength, Ensure Immune Health, Ensure Bone Health, Ensure or Ensure Plus.
Milk drinkers maintain healthy weight, study finds
WASHINGTON Milk drinkers are more likely to lose weight than those who skip drinking milk when on a diet, a study published in the American Journal of Clinical Nutrition suggested.
In a two-year study, researchers observed 300 overweight or at-risk men and women ages 40 to 65 years. The participants were put on low-fat, Mediterranean or low-carb diets for two years, but regardless of diet, those that consumed 580 mg of milk per day (about two glasses), lost about 12 lbs., compared with those with the lowest dairy calcium intake (averaging about 150 mg, or about half of a glass), in which participants lost just 7 lbs.
Beyond calcium, the researchers also found that vitamin D levels independently affected weight loss success, and, in line with previous research, milk and milk products were the top contributors to vitamin D in the diets of the study participants.
The study, "Dairy calcium intake, serum vitamin D and successful weight loss," was published in the Sept. 1 edition of the journal.